Basel Medical Group Ltd Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Basel Medical Group Ltd (BMGL) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of SGD 1.56 million for the 12-month period ending 2025-06-30, per its 20-F/A filed 2026-03-13.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-03-13
SGD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month as first filed |
|---|---|---|
| 2025-06-30 | 1.56M SGD 20-F/A · filed 2026-03-13 | 1.52M SGD 20-F · filed 2025-11-18 |
| 2024-06-30 | 733.61K SGD 20-F/A · filed 2026-03-13 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month as first filed |
|---|---|---|
| 2025-06-30 | $1.22M 20-F/A · filed 2026-03-13 | $1.20M 20-F · filed 2025-11-18 |